PLPL - Plandaí Biotechnology, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.0119
-0.0001 (-0.83%)
At close: 3:23PM EDT
Stock chart is not supported by your current browser
Previous Close0.0120
Open0.0119
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0119 - 0.0130
52 Week Range0.0100 - 0.0300
Volume674,768
Avg. Volume1,813,751
Market Cap2.22M
Beta-1.21
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
All
News
Press Releases
  • GlobeNewswire12 hours ago

    Plandai Biotechnology’s Phytofare® Green Tea Catechins as a Phytogenic Substance in Poultry Diets

    Based on the results of published studies, the addition of generic green tea catechins to the diets of both broilers and layers has been shown to improve the productive performance and reduce the cholesterol content in the serum and egg yolk, implying its potential effect on egg-quality parameters. Furthermore, the addition of generic green tea catechins in the chickens’ diet decreases all microflora counts in the caecum due to an antibiotic-like effect. In this review, it was found that green tea catechins’ inclusion in broiler diets had positive effects on growth performance and lean meat production, whereas catechins in high dosage tended to decrease feed intake and body weight gain but delivered an improved feed conversion ratio.

  • GlobeNewswire6 days ago

    Plandai Biotechnology Addresses Opportunities in the South African and Global Poultry Industries

    Plandai Biotechnology Inc. (OTC Markets: PLPL) (the “Company” or “Plandai”), a producer of nutraceutical and highly phyto-available extracts, is pleased to provide background on the current known issues in the global poultry industry and its identification of potential opportunities. Globally, more than 58 billion chickens are raised annually as a source of food, for both their meat and eggs. Chicken producers use nationally approved medications, such as antibiotics and antivirals in feed or drinking water, to treat disease or to prevent disease outbreaks.  As a result of the ban on the use of antibiotic growth promoters in animal diets in the European Union as from January 2006, and the growing pressure on poultry producers in other parts of the world, alternative substances and strategies for animal health and growth promotion are now necessary.

  • GlobeNewswire13 days ago

    Plandai Biotechnology’s Phytofare Gaining Traction in International Markets

    Plandai Biotechnology, Inc. (OTC Markets: PLPL) (the “Company” or “Plandai”), a producer of nutraceutical and highly phyto-available extracts, is pleased to provide an update on its successful roll-out of its Phytofare® supplement. Plandaí Biotech’s Phytofare®, is the only clinically proven green tea extract shown to be bioavailable. Generic green tea extracts are thought to have bioavailability of between 1-10% whereas Phytofare® has shown in a human bioavailability study to have a bioavailability of 10 times that of generic green tea extract.

  • GlobeNewswire19 days ago

    Plandai Biotechnology’s Phytofare® Utilizes Green Tea to Fight Type 2 Diabetes

    Plandai Biotechnology Inc. (OTC Markets: PLPL) (the “Company” or “Plandai”), a producer of nutraceutical and highly phyto-available extracts, is pleased to provide an update to its Phytofare solution as a preventive mitigation against Type 2 diabetes. In looking for a natural solution, epidemiological studies indicate that populations with a high intake of green tea catechins benefit in terms of reduced body weight, body fat, the balance of insulin and glucagon, maintaining blood glucose, and cardiovascular health.

  • GlobeNewswire22 days ago

    Plandai Biotechnology Discusses How Green Tea Combats Type 2 Diabetes

    Plandai Biotechnology Inc. (OTC Markets: PLPL) (the “Company” or “Plandai”), a producer of nutraceutical and highly phyto-available extracts, is pleased to discuss green tea and its positive natural attributes in helping to prevent and fight Type 2 diabetes. Generally, diabetes is a chronic disease that occurs either when the pancreas does not produce enough insulin or when the body cannot effectively use the insulin it produces. Insulin is a hormone that regulates blood sugar.

  • GlobeNewswire27 days ago

    Plandai Biotechnology Provides Background on its Past and Present Cannabis Initiatives

    Company History in Cannabis Research Dates Back to February 2013. LONDON, UNITED KINGDOM, April 25, 2018-- Plandai Biotechnology Inc., a producer of nutraceutical and highly phyto-available extracts, today ...

  • GlobeNewswirelast month

    Plandai Biotechnology Discusses Cannabis Strategy, Research and Business

    Plandai Biotechnology Inc. (OTC Markets: PLPL) (the “Company” or “Plandai”), a producer of nutraceutical and highly phyto-available extracts, is pleased to provide an update on its cannabis business strategy and opportunities. Using the Company’s proprietary processing technology, Plandaí intends to establish that it can produce a full-profile cannabis extract, Phytofare® Cannabis Complex, that contains both CBD and the precursor acid form of THC found in live cannabis plant. Based on prior, successfully, published USD/Plandai bioavailability studies with oil based fruits, Plandaí’s hypothesis is that the resultant extract will have the superior bioavailability of other Phytofare® extracts with the added benefit of being non-psychoactive.

  • GlobeNewswirelast month

    Plandai Biotechnology Provides Update on its Convertible Debt

    Previously Issued Convertible Notes Now in Friendly Shareholder Hands. LONDON, UNITED KINGDOM, April 12, 2018-- Plandai Biotechnology Inc., a producer of nutraceutical and highly phyto-available extracts, ...

  • GlobeNewswirelast month

    Plandai Biotechnology Addresses Bioavailability and the Science of Phytofare

    Human Clinical Trial Results and Key Benefits. Phytofare Catechin Complex is Superior to Generic Green Tea Extracts. LONDON, UNITED KINGDOM, April 10, 2018-- Plandai Biotechnology Inc., a producer of nutraceutical ...

  • GlobeNewswire2 months ago

    Plandai Biotechnology Provides Update to Its Proprietary Technology

    Phytofare Clinically Proven to Dramatically Improve Absorption. LONDON, UNITED KINGDOM, April 03, 2018-- Plandai Biotechnology Inc., a producer of nutraceutical and highly phyto-available extracts, today ...

  • GlobeNewswire2 months ago

    Plandai Biotechnology Appoints Paritz & Company as New Auditor

    Performing Two Year Audit for Plandaí to Become Current and SEC Compliant. LONDON, UNITED KINGDOM, March 27, 2018-- Plandaí Biotechnology Inc., a producer of nutraceutical and highly phyto-available extracts, ...

  • GlobeNewswire2 months ago

    Plandai Biotechnology Issues Business Targets and Milestones for Remainder of 2018

    Looking to Ramp Commercialization and Accelerate Revenue Growth. LONDON, UNITED KINGDOM, March 20, 2018-- Plandaí Biotechnology Inc., a producer of nutraceutical and highly phyto-available extracts, today ...

  • GlobeNewswire2 months ago

    Plandai Biotechnology Engages Hayden IR to Develop Comprehensive Investor Relations Program

    Focused on Increasing Awareness and Enhancing Shareholder Value. Plans to Return to Active SEC Reporting Status. LONDON, UNITED KINGDOM, March 12, 2018-- Plandai Biotechnology Inc., a producer of nutraceutical ...